Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Markel GroupMKL -0.88%82 3-Year EBITDA Growth Rate is 115.20% as of Jun. 2026, which is 673% above its 10-year median of 14.90. GuruFocus rates MKL with a GF Score™ of 82/100 and a GF Value™ of $2,194.21 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 290 Insurance companies, Markel Group ranks better than 95.52% on this metric.
During the past 12 months, Markel Group's average EBITDA Per Share Growth Rate was 2.30% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 115.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 22.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 18.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Markel Group was 188.20% per year. The lowest was -49.00% per year. And the median was 14.90% per year.
Markel Group (NYSE:MKL) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Markel Group 3-Year EBITDA Growth Rate Related Terms
MKL vs L, WRB, CINF: 3-Year EBITDA Growth Rate Comparison
For the Insurance - Property & Casualty subindustry, Markel Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Markel Group 3-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Markel Group's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Markel Group's 3-Year EBITDA Growth Rate falls into.
Markel Group 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 115.20% mean?
Markel Group (MKL) has a 3-Year EBITDA Growth Rate of 115.20% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Markel Group and its competitors. This is 673% above median its historical median of 14.90. According to the industry distribution chart, Markel Group ranks #13 out of 290 companies in the Insurance industry, placing it in the top 4.5%.
Is Markel Group's 3-Year EBITDA Growth Rate too high?
Markel Group's current 3-Year EBITDA Growth Rate of 115.20% is 673% above median its 10-year median of 14.90. The Insurance industry median 3-Year EBITDA Growth Rate is 15.55. Markel Group's value of 115.20% is 640.8% above this industry median. Based on the distribution chart, Markel Group ranks #13 out of 290 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Markel Group has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Markel Group's 3-Year EBITDA Growth Rate compare to L and WRB?
According to the Insurance industry distribution chart, Markel Group ranks #13 out of 290 companies for 3-Year EBITDA Growth Rate. This places Markel Group in the top 5% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 15.55. Markel Group's value of 115.20% is 640.8% above this benchmark. While the company's 10-year median is 14.90 vs. the industry median of 15.55, Markel Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Insurance company?
The median 3-Year EBITDA Growth Rate among Insurance companies is 15.55, based on 290 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Markel Group's current 3-Year EBITDA Growth Rate of 115.20% is 640.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Markel Group and its competitors. For the Insurance industry, the median 3-Year EBITDA Growth Rate is 15.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Markel Group's current 3-Year EBITDA Growth Rate is 115.20%, which is 673% above median its own 10-year median of 14.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Markel Group stock overvalued right now?
Based on GuruFocus' analysis, Markel Group (MKL) is currently considered Modestly Undervalued. The stock's GF Value™ is $2,194.21, compared to a current price of $1,826.72 — trading 16.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 115.20%, which is 673% above median its 10-year median of 14.90 and 640.8% above the Insurance industry median of 15.55. Markel Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Markel Group (MKL), the current 3-Year EBITDA Growth Rate is 115.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Markel Group (MKL) Overvalued in 2026?
Based on GuruFocus' analysis, Markel Group stock appears to be undervalued.
The current stock price of $1,826.72 is trading 16.7% below its estimated GF Value™ of $2,194.21.
GuruFocus considers Markel Group to be Modestly Undervalued.
Key valuation signals for MKL:
3-Year EBITDA Growth Rate: 115.20% (673% above median its 10-year median of 14.90)
GF Value™: $2,194.21 vs. price of $1,826.72 (16.7% below fair value)
Industry Position: 640.8% above the Insurance median (#13 of 290)
No single metric tells the full story. See the MKL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
82GF Score
Get the complete analysis for MKL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKL has been successfully added to your 
